Skip to main content

Dizziness

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Otolith Labs
Otolith LabsDC - Washington
3 programs
OtobandN/A1 trial
OtobandN/A
OtobandN/A1 trial
Active Trials
NCT04226976Suspended40Est. Jun 2024
NCT03886012Suspended40Est. Dec 2021
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
OtobandN/A1 trial
Active Trials
NCT05157399Completed28Est. Sep 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Otolith LabsOtoband
Angeles TherapeuticsOtoband
Otolith LabsOtoband

Clinical Trials (3)

Total enrollment: 108 patients across 3 trials

Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy

Start: Jun 2022Est. completion: Jun 202440 patients
N/ASuspended

Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness

Start: Nov 2021Est. completion: Sep 202228 patients
N/ACompleted

Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo

Start: Apr 2019Est. completion: Dec 202140 patients
N/ASuspended

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.